EXHIBIT ADevelopment and Licensing Agreement • March 3rd, 2006 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • California
FIRST AMENDMENT AND SUPPLEMENT (“this Amendment”) dated as of November 15, 2005 to the DEVELOPMENT AND LICENSING AGREEMENT (“the Original Agreement” and, as amended and supplemented by this Amendment, “the Agreement”) dated as of September 27, 1996, by and between GILEAD SCIENCES, INC., a Delaware Corporation (“Gilead”), on the one hand, and F. HOFFMANN-LA ROCHE LTD, a corporation organized under the laws of Switzerland, and HOFFMANN-LA ROCHE INC., a corporation organized under the laws of New Jersey, on the other hand (collectively “Roche”). Capitalized terms used but not defined herein shall have the meanings assigned them in the Original Agreement.
Restated and Amended Toll Manufacturing Agreement by and among Gilead Sciences Limited Unit 13, Stillorgan Industrial Park Blackrock, Co. Dublin, Ireland Gilead Sciences, Inc. Foster City, CA 94404 USA and ALTANA Pharma Oranienburg GmbH Lehnitzstr....Clinical and Commercial Supply Agreement • March 3rd, 2006 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
This Restated and Amended And Restated Clinical and Commercial Supply Agreement (the “Agreement”) is entered into and made effective as of November 7, 2005 (the “Effective Date”) among, on the one hand, Gilead Sciences Limited., an Irish limited Company (“GSL”), whose registered address is Unit 13, Stillorgan Industrial Park, Blackrock, Co. Dublin, Ireland, and Gilead Sciences, Inc, a Delaware corporation (“GSI”) with its principal office located at 333 Lakeside Drive, Foster City, CA 94404, USA (Gilead World and Gilead Sciences collectively, “GILEAD”), and, on the other hand, Altana Pharma Oranienburg GmbH, a German corporation (“APO”) having its principal place of business at Lehnitzstrasse 70-98, 16515 Oranienburg, Germany. Gilead and APO are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
